The U.S. online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.
GoodRx did not immediately respond to a request for comment.
GoodRx sells shares in IPO above target range – source
4 years ago
No Comments
Related Posts
Spain set to pass law requiring 40% of company boards to be women
March 6, 2023
PGA revokes 2022 championship from Trump’s Bedminster golf course
January 11, 2021
Meet the app that wants to be the Bumble of real estate
October 6, 2020
‘I think most of our inflation is behind us.’ Top economist Jeremy Siegel says we’ve reached the peak
July 14, 2022
Where’s the bottom for stocks? By this important measure, they may have hit fair value
March 24, 2020
Investor enthusiasm for reopened China fades amid wariness of Xi Jinping’s unchecked power
February 26, 2023
About The Author
